Practical LC–MS Workflows for siRNA and sgRNA Characterization Using a Single-Quadrupole Mass Spectrometer

Importance of the topic

The rapid expansion of oligonucleotide therapeutics (siRNA, sgRNA) drives demand for practical, reliable analytical workflows for molecular-weight confirmation, impurity profiling and verification of duplex integrity. Laboratories that lack high-resolution MS instrumentation benefit from validated approaches that use single-quadrupole LC–MS with an extended mass range to deliver routine confirmatory data with simplified operation, rapid throughput and fit-for-purpose accuracy for QC and R&D applications.

Objectives and overview of the study

This work describes practical LC–MS workflows based on a single-quadrupole mass spectrometer (Shimadzu LCMS-2050 with extended range to 3000 m/z) coupled to an inert UHPLC (Nexera XSi) for characterizing synthetic guide RNA (sgRNA, ~32.3 kDa) and siRNA (21-mer duplex, ~13.4 kDa). Goals included: demonstrating molecular-weight confirmation, comparing ion-pairing mobile phases for charge-state control and chromatographic separation, assessing intact-duplex analysis under non-denaturing conditions, and establishing automated impurity profiling using vendor software.

Methodology

• Samples: Synthetic oligonucleotides purchased from Integrated DNA Technologies (single-strand sgRNA and a 21-mer siRNA duplex, sequences provided).
• Chromatography: Shim-pack Scepter Claris C18-300 (150 x 2.1 mm, 1.9 µm) under inert LC conditions; gradient mode; flow 0.2 mL/min; PDA detection at 260 nm.
• Mobile phases tested: multiple ion-pairing systems including HFIP/TEA/TEAA, tributylammonium acetate (TBuAA) ± organic modifier, hexylammonium acetate (HAA), and TEAA-based mixes. Conditions were varied to modulate charge states and separation.
• Mass spectrometry: LCMS-2050 operated in negative ESI/APCI (DUIS) mode, interface −2.0 kV, scan (profile) 500–3000 m/z, desolvation 450 °C, DL 200 °C; nebulizing/drying/heating gas flows optimized as reported.
• Data processing and method optimization: LabSolutions MD used for automated chromatographic method optimization and design-space generation; Insight Biologics used for deconvolution, quick-picking of peaks and automated impurity calculation.

Used Instrumentation

• Nexera XSi inert UHPLC system.
• Shimadzu LCMS-2050 single-quadrupole mass spectrometer with extended mass range to 3000 m/z.
• Shim-pack Scepter Claris C18-300 column (150 mm × 2.1 mm, 1.9 µm).
• PDA detector (SPD-M40) for 260 nm monitoring.
• Software: LabSolutions MD for LC method optimization; Insight Biologics (v2.2) for deconvolution and impurity profiling.

Results and discussion

Mass confirmation and charge-state behavior

• sgRNA: Using the LCMS-2050 with extended m/z range and appropriate ion-pairing mobile phases, the sgRNA molecular weight was deconvoluted to 32,275.06 Da with a typical mass error under 1 Da across repeated measurements, demonstrating sufficient nominal-mass accuracy for synthesis confirmation on a single-quadrupole platform.
• siRNA: Both single strands and the intact duplex were observed. Under non-denaturing chromatographic conditions (oven temperature < 28 °C) and inert LC setup, the duplex remained intact and the extended mass range allowed its detection and deconvolution (~13.4 kDa).

Effect of ion-pairing reagents and ion source tuning

• TBuAA and HAA ion-pairing agents produced shifts toward lower charge states (i.e., higher m/z), facilitating observation on the single-quadrupole detector; however, magnitude of shifts was modest and dependent on solvent composition.
• Adduct formation (e.g., HFIP or other volatile modifiers) is common with ion-pairing agents. Optimization of ion-source parameters on the LCMS-2050 reduced adducts, increased total ion counts and improved deconvolution results.

Chromatographic optimization and impurity profiling

• LabSolutions MD enabled automated method optimization and ranking of separation conditions, allowing efficient selection of robust chromatographic parameters across ion-pairing chemistries.
• Insight Biologics successfully deconvoluted single-stranded siRNA spectra and automatically reported impurity profiles and relative abundances (example impurity species reported in the study at single-digit percent levels).

Benefits and practical applications of the method

• Accessibility: Single-quadrupole LC–MS with extended range provides a pragmatic option for many QC and research labs that do not have high-resolution MS, delivering confirmatory molecular-weight data and impurity screening.
• Flexibility: Multiple ion-pairing chemistries can be screened rapidly, and automated LC optimization accelerates method development.
• Duplex analysis: Maintaining low oven temperatures and inert LC conditions enables non-denaturing analysis to monitor intact siRNA duplexes, relevant for potency and stability assessments.
• Workflow integration: Coupling LabSolutions MD and Insight Biologics offers an efficient pipeline from method development to automated deconvolution and impurity reporting suitable for routine use.

Limitations and considerations

• Resolution and mass accuracy: Unit-resolution single-quad instruments cannot match high-resolution MS for elemental composition or very close mass variants; identification of isobaric impurities or small mass shifts may be limited.
• Adducts and ion-pairing artifacts: Ion-pairing chemistries increase adduct formation and complicate spectra; careful source tuning and solvent selection are required.
• Dependence on software deconvolution: Accurate reporting relies on robust deconvolution algorithms; validation of software output against orthogonal methods is advisable for critical QC decisions.

Future trends and applications

• Hybrid workflows: Combining single-quad workflows for routine QC with intermittent high-resolution MS or orthogonal techniques for detailed impurity characterization will provide balanced cost and information depth.
• Improved ion-pairing strategies: Development of volatile, low-adduct-forming ion-pair reagents and optimized solvent systems will improve signal clarity on nominal-mass instruments.
• Native MS and intact oligonucleotide analytics: Advancements in instrumentation and source design will expand capabilities for intact duplex and higher-order structure analysis even on benchtop systems.
• Automation and regulatory adoption: Enhanced software automation for chromatographic optimization, deconvolution, and reporting will streamline QC workflows and support regulatory reporting for oligonucleotide therapeutics.

Conclusion

The study demonstrates that a single-quadrupole LC–MS system with extended mass range, when combined with targeted chromatographic conditions, ion-source tuning and vendor software (LabSolutions MD and Insight Biologics), can deliver practical and reliable molecular-weight confirmation and impurity profiling for sgRNA and siRNA. While unit-resolution MS has intrinsic limitations compared with high-resolution instruments, the described workflows provide a cost-effective, robust approach for routine analytical environments and QC screening of oligonucleotide therapeutics.

References

• Johnson V., Luo K., Suzuki R., Toyama A., Dahl J., Uchiyama K., Matsubara T. Practical LC–MS Workflows for siRNA and sgRNA Characterization Using a Single-Quadrupole Mass Spectrometer. Shimadzu application note / poster (authors affiliated with Shimadzu Scientific Instruments and Shimadzu Corporation). Experimental details include Nexera XSi UHPLC, LCMS-2050, LabSolutions MD and Insight Biologics software; samples from Integrated DNA Technologies.